How safe and effective is denosumab for bone giant cell tumour?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Orthopedics and Sports Medicine,Surgery
Link
http://link.springer.com/article/10.1007/s00264-017-3536-9/fulltext.html
Reference24 articles.
1. Klenke FM, Wenger DE, Inwards CY et al (2011) Giant cell tumor of bone: risk factors for recurrence. Clin Orthop 469:591–599. doi: 10.1007/s11999-010-1501-7
2. Errani C, Ruggieri P, Asenzio MAN et al (2010) Giant cell tumor of the extremity: a review of 349 cases from a single institution. Cancer Treat Rev 36:1–7. doi: 10.1016/j.ctrv.2009.09.002
3. van der Heijden L, Dijkstra PDS, van de Sande MAJ et al (2014) The clinical approach toward giant cell tumor of bone. Oncologist 19:550–561. doi: 10.1634/theoncologist.2013-0432
4. Balke M, Schremper L, Gebert C et al (2008) Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol 134:969–978. doi: 10.1007/s00432-008-0370-x
5. Kivioja AH, Blomqvist C, Hietaniemi K et al (2008) Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian sarcoma group study of 294 patients followed for a median time of 5 years. Acta Orthop 79:86–93. doi: 10.1080/17453670710014815
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combined preoperative denosumab and adjuvant microwave ablation for high-risk giant cell tumor of bone: a retrospective study in a single center;Journal of Orthopaedic Surgery and Research;2024-08-17
2. Giant-cell Tumor of Dorsal Vertebra Presenting as a Posterior Mediastinal Mass: A Rare Case Report;The Indian Journal of Chest Diseases and Allied Sciences;2024-07-10
3. Adjuvant denosumab treatment in patients with resectable high-risk giant cell tumor of bone;Anatolian Current Medical Journal;2024-05-28
4. Central giant cell granuloma of the jaws—long-term clinical and radiological outcomes of surgical and pharmacological management;Clinical Oral Investigations;2024-03-07
5. Adverse drug events of denosumab: Data-mining based on the United States Food and Drug Administration Adverse Event Reporting System database;Journal of Research in Pharmacy;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3